Stock Valuation / MDAI
Is Spectral AI, Inc. (MDAI) Overvalued? Fair Value & 5-Year Target
Spectral AI, Inc. trades at $1.56 (P/E -4.73). Our reference model estimates a fair value of $-0.46 at its recent average P/E of 1.41.
| Current price | $1.56 |
|---|---|
| Current EPS | $-0.33 |
| Current P/E | -4.73 |
| Average P/E | 1.41 |
| Fair value (at avg P/E) | $-0.46 |
| Upside to fair value | -129.7% |
What drives MDAI's valuation
Changing either assumption moves the target: a higher P/E multiple or faster EPS growth raises fair value, a lower multiple or slower growth lowers it. The interactive dashboard lets you edit both and re-run the model instantly.
About Spectral AI, Inc.
Spectral AI, Inc., an artificial intelligence (AI) company, focuses on predictive medical diagnostics in the United States. The company offers DeepView System, which uses proprietary AI algorithms to distinguish between fully damaged, partially damaged, and healthy human tissue characteristics invisible to the naked eye at the initial time point of wound presentation and delivers a binary prediction on the wounds capacity to heal by a specified time point in the future to assist the physician in making a more accurate, timely, and informed decision regarding the treatment of the patient's wounds. Its system also develops AI-Burn software and MSI imaging technology, which consists of propriet
Frequently asked questions
What is MDAI's fair value?
At its recent average P/E of 1.41, Spectral AI, Inc. (MDAI) has a reference fair value of about $-0.46, which is -129.7% versus the current price of $1.56.
Is Spectral AI, Inc. (MDAI) overvalued or undervalued?
Based on the average-P/E reference model, Spectral AI, Inc. looks overvalued relative to fair value by roughly +129.7%. This is a model output, not investment advice — change the P/E and growth assumptions in the dashboard for your own view.
Open the interactive MDAI valuation dashboard →
Figures are for informational purposes only and are not investment advice. Data as of 2026-10-14.